News

 

At AseBio, we follow the latest news in the biotechnology sector and pass the highlights on to you. You can use the search engine to find news articles we’ve written, contributed by our members or from other stakeholders in the sector. And they are also organised into categories to help you find the topics you’re interested in easily.

Search engine
illumina
Introducing Illumina Connected Analytics
Healthcare · Agrifood · Gene editing · International
Analyze, manage, aggregate, and explore data at scale with Illumina Connected Analytics, a…
Partners - Illumina
illumina
Multiomics is revolutionizing research, here’s why
Learn why research leaders decided to use Multiomics in their work.  
Partners - Illumina
enero 2022 bcn
BCN HEALTH publishes a study evaluating the influence of disease severity on healthcare costs among hospitalized NAFLD/NASH patients in Spain
BCN HEALTH realizó un estudio retrospectivo basado en los registros de pacientes hospitalizados por…
Partners - BCN Health
foto oryzon
ORYZON announces approval for Serbian arm of PORTICO, vafidemstat’s Phase IIb trial in Borderline Personality Disorder
Healthcare
Serbian arm final deployment in PORTICO. Study already active in Spain, Bulgaria, Germany and USA…
Partners - Oryzon Genomics
oryzon
ORYZON to hold multiple corporate activities in January
Healthcare · Advanced therapies
40º Annual J.P. Morgan Healthcare Conference Biotech Showcase 2022 11º Annual LifeSci Partners…
Partners - Oryzon Genomics
joan y bernat sanifit
Two chemists who founded Sanifit: “Biotech entrepreneurship isn’t a sprint. It’s an ultramarathon”
Healthcare · Rare diseases · Innovative drugs
Two chemists, when they had barely turned 25, set up a spin-off of the University of the Balearic…
ITEMAS
GENESIS Biomed sponsors the ITEMAS 2021 Annual Conference
The Instituto Aragonés de Ciencias de la Salud (IACS) and the Instituto de Investigación Sanitaria…
Partners - GENESIS Biomed
oryzon pic
ORYZON at ASH-2021: iadademstat 36-month ALICE data demonstrate robust efficacy in combination with azacitidine in AML
Healthcare
Robust efficacy - ORR 78%, of which 62% are CR/CRi 77% of CR/CRi lasting more than 6 months…
Partners - Oryzon Genomics
Integra Therapeutics
Integra Tx secures €4.5-million in funding from Advent France Biotechnology, Invivo Capital and Takeda Ventures
The investment will be used to develop an innovative gene editing platform with the potential to…
Partners - Integra Therapeutics S.L.